Climacteric

Papers
(The TQCC of Climacteric is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Peer reviewers for Climacteric in 2024108
Variations in the prevalence of premature and early menopause in low and middle-income regions: a cross-sectional study68
Pregnancy-associated risk factors for future cardiovascular disease – early prevention strategies warranted45
Safety and acceptability of intravaginal rings releasing estradiol and progesterone42
Low thrombin generation in postmenopausal women using estetrol36
Expanding knowledge across medical specialties in menopause research and practice: why it is so important for women’s health35
Effects of jazz dance and concurrent training on physical variables in postmenopausal women31
Influence of estradiol deficiency on the mineralocorticoid receptor response in postmenopausal women: a cross-sectional study30
Awareness of menopause and menopause hormone therapy in India: perspectives of healthcare providers and consumers28
Relationship between menopausal hormone therapy and incidence of fractures in postmenopausal women28
Peer reviewers for Climacteric in 202226
Recent advances in the management of postmenopausal women with non-atypical endometrial hyperplasia25
Pharmacokinetics, safety and preliminary pharmacodynamic evaluation of DARE-VVA1: a soft gelatin capsule containing tamoxifen for the treatment of vulvovaginal atrophy24
Women’s experience and management of cognition during menopause transition: a qualitative study21
The musculoskeletal syndrome of menopause21
Androgen therapy in midlife and older women: a position statement of the Latin American Association of Gynecological Endocrinology (ALEG)21
Ultra-low-dose estradiol and dydrogesterone for treatment of vasomotor symptoms in Europe and China20
Quo vadis?19
‘Menopausando’: a digital health education platform for women in the transition to menopause and postmenopause17
Treatment, perceptions and burden of vasomotor symptoms among midlife women in Japan17
Good night and good luck17
Comparison of predicted aerobic capacity to measured aerobic capacity in menopausal women: an analysis of three methods16
Does climacteric status impact regulation of the autonomic nervous system at the age of 46 years?16
The impact of ovarian aging on muscle strength and life quality in various reproductive aging stages15
Satisfaction and medication adherence in women with vulvovaginal atrophy: the CRETA15
Association of serum uric acid with handgrip strength and dynapenia in postmenopausal women14
Ellen Theresia Maria Laan (April 3, 1962–January 22, 2022)14
Menopausal symptoms among perimenopausal women in rural Turkey: a cross-sectional study14
Menopausal hormone therapy: what are the problems in the perception of Chinese physicians?14
Hormone therapy and insulin resistance in non-diabetic postmenopausal women: a systematic review and meta-analysis14
Effect of estrogen on vaginal complications of pessary use: a systematic review and meta-analysis14
VDRgeneApaI polymorphism and risk of postmenopausal osteoporosis: a meta-analysis from 22 studies13
A bibliometric analysis of primary ovarian insufficiency from 2010 to 202013
The LADY study: epidemiological characteristics of prevalent and new genitourinary syndrome of menopause cases in Greece13
Resveratrol promotes bone mass in ovariectomized rats and the SIRT1 rs7896005 SNP is associated with bone mass in women during perimenopause and early postmenopause13
Thank you12
What is the evidence for the effect of physical exercise on bone health in menopausal women? An umbrella systematic review12
Not just sex: other roles for testosterone in women12
Impact of non-hip fractures in elderly women: a narrative review12
Low-dose and ultra-low-dose estradiol and dydrogesterone in postmenopause: an analysis by body mass index12
Progesterone and not estrogens or androgens causes breast cancer12
NK3 receptor antagonist alters the centrally controlled perception of menopausal flushing – a pilot study11
Practices and challenges in the management of the menopause in the Asia-Pacific Menopause Federation11
Reproductive milestones across the lifespan and cardiovascular disease risk in women11
Postmenopausal women’s adherence to pelvic floor muscle exercises over 2 years10
Factors influencing seogeulpeum among middle-aged Korean women10
Menopausal age and cardiovascular disease risk in American women: evidence from the National Health and Nutrition Examination Survey10
Understanding experiences and views of the menopause in Zimbabwe and South Africa: a qualitative study10
COVID-19-related premature ovarian insufficiency: case report and literature review10
The next chapter10
Adjuvant treatment with tamoxifen for estrogen receptor-positive breast cancer and gynecological risks in premenopausal and perimenopausal women – a systematic review9
Management of obesity in menopause9
Is the patients’ fear of cancer the main barrier to prescribing menopausal hormone therapy?9
Systemic hormone therapy after breast and gynecological cancers: an Italian expert group consensus opinion9
Safety of menopause hormone therapy in postmenopausal women at higher risk of venous thromboembolism: a systematic review9
Effects of exercise on vasomotor symptoms in menopausal women: a systematic review and meta-analysis9
POESIT recommendations on management of body-identical hormones in menopausal symptoms9
FNDC5/Irisin polymorphisms are associated with osteopenia in postmenopausal Mayan-Mestizo women8
Estrogen as a guardian of auditory health: Tsp1–CD47 axis regulation and noise-induced hearing loss8
Neuroprotective effect of hormone replacement therapy: a review of the literature8
In search of a well-balanced narrative of the menopause momentum8
Therapeutic effects of curculigoside on cyclophosphamide-induced premature ovarian failure in mice8
Menopausal hormone therapy: why we should no longer be afraid of the breast cancer risk8
Menopause hormone treatment after cancer8
Safety of prasterone in breast cancer survivors treated with aromatase inhibitors: the VIBRA pilot study8
Prevalence, impact and management of postmenopausal symptoms among postmenopausal women in Rwanda8
Impact of overweight and obesity in postmenopausal women8
Management of menopause: a survey of physicians from the Middle East and Africa8
Premature ovarian insufficiency: addressing the most controversial issues8
The yin and yang of GSM and low sexual desire8
The association between day-to-day impact of vaginal aging and female sexual function8
The impact of menopause education on quality of life among menopausal women: a systematic review with meta-analysis7
REDLINC: two decades of collaborative insights into menopause and women’s health in Latin America7
Is it possible that menopause is associated with telomere length? Findings of an integrative review7
Sleep disorders and menopausal symptoms: a Latin American perspective on postmenopausal health7
Reflections7
Testosterone for women: certainties and uncertainties7
Corneal thickness, contrast sensitivity and binocular vision in menopausal and non-menopausal women7
Psychosomatic and medical experiences of menopause in Chinese women: a social media study6
Peer reviewers for Climacteric in 20236
The mediating role of socioeconomic status on the relationship between pregnancy history and later-life cognition6
Pulmonary embolism in menopausal hormone therapy: a population-based register study6
Effect of hormone therapy on personality traits: preliminary evidence in older men and women6
Endocrine consequences of breast cancer therapy and survivorship6
The role of lifestyle medicine in menopausal health: a review of non-pharmacologic interventions6
First live birth in China after cryopreserved ovarian tissue transplantation to prevent premature ovarian insufficiency6
Higher testosterone is associated with higher HDL-cholesterol and lower triglyceride concentrations in older women: an observational study6
Acupuncture and Chinese herbal medicine for menopausal mood disorder: a randomized controlled trial6
IMS World Congress on Menopause6
0.35578608512878